CELEOS

Is developing a real-time surgical guidance technology combining laser, mass spectrometry and artificial intelligence. Its innovative system enables precise identification of tumour tissue and surgical margins, optimising tumour removal while preserving healthy tissue. The aim of this approach is to reduce the risk of relapse and improve the outcome of oncology operations.